Product Information

PALIPERIDONE ER 1.5 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.7259 per EA under NDC 43975034903. Its NADAC has been published 329 times since May 6, 2020.

FDA first approved this application on Jun 12, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PALIPERIDONE ER 1.5 MG TABLET

PALIPERIDONE
$0.7259per EA

Strength

1.5 mg/1

NDC

43975034903

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PALIPERIDONE

Approval Type

Generic (ANDA)

FDA Application

ANDA204452

FDA Approved

6/12/2019

TE Code

AB

On Market Since

11/27/2019

Pharmacological Classes

Price Statistics

The NADAC for PALIPERIDONE ER 1.5 MG TABLET has been published 329 times since May 6, 2020, and over the history we have for it it has declined 90.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7259 per EA
All-time high$8.7151 (Jul 15, 2020)
All-time low$0.7259 (Aug 19, 2026)
52-week high$1.1119
52-week low$0.7259
Median price$1.8445
Average price$3.1795
Largest weekly change+46.9% (Oct 19, 2022)
Weeks tracked329
Tracking sinceMay 6, 2020

Price History

1W

-10.4%

1M

-10.4%

3M

-16.2%

6M

-25.8%

1Y

-34.5%

3Y

-48.6%

5Y

-88.9%

All

-90.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PALIPERIDONE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of PALIPERIDONE ER 1.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PALIPERIDONE ER 1.5 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.7259 per EA (NDC 43975034903), effective Aug 19, 2026.

How has the price of PALIPERIDONE ER 1.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for PALIPERIDONE ER 1.5 MG TABLET has declined 90.4%. It has been tracked across 329 weekly CMS publications since May 6, 2020.

What are the highest and lowest recorded NADAC prices for PALIPERIDONE ER 1.5 MG TABLET?

Since May 6, 2020, the NADAC for PALIPERIDONE ER 1.5 MG TABLET has ranged from a low of $0.7259 (Aug 19, 2026) to a high of $8.7151 (Jul 15, 2020), with a median of $1.8445 per EA.

Are there cheaper alternatives to PALIPERIDONE ER 1.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PALIPERIDONE ER 1.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PALIPERIDONE ER 1.5 MG TABLET?

PALIPERIDONE ER 1.5 MG TABLET (NDC 43975034903) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.